ActiveRADAR Therapeutic Alternative Service and Value-Based Reimbursement Programs Now Includes 86 Therapeutic Classes.

At its February P&T Committee meeting, ActiveRADAR added Biologic Immunomodulators and 5 other drug classes to its list of Therapeutic Alternatives Service (AR-TAS) and Value-based Reimbursement program.  In addition to the specialty drug products used for managing autoimmune conditions like rheumatoid arthritis, inflammatory bowel disease and psoriasis, ActiveRADAR added five other drug classes / health…